Mark Lee
- Cancer Research top 2%
- Oncology top 5%
- Molecular Biology
- Pathology and Forensic Medicine top 5%
- Pulmonary and Respiratory Medicine top 10%
- Co-authors
- Stefanie S. JeffreyMichail IgnatiadisAlexander M. AravanisRichard D. KlausnerKevin StruhlFrederick L. BaehnerDrew WatsonDavid Kerr
- Topics
- Genetic factors in colorectal cancer (11 papers)Cancer Genomics and Diagnostics (8 papers)Lung Cancer Treatments and Mutations (6 papers)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Mark Lee
52 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 117
- Cancer Research 698
- Oncology 674
- Molecular Biology 557
- Pathology and Forensic Medicine 332
- Pulmonary and Respiratory Medicine 332
Countries citing papers authored by Mark Lee
This map shows the geographic impact of Mark Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Lee more than expected).
Fields of papers citing papers by Mark Lee
This network shows the impact of papers produced by Mark Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Lee. The network helps show where Mark Lee may publish in the future.
Co-authorship network of co-authors of Mark Lee
This figure shows the co-authorship network connecting the top 25 collaborators of Mark Lee. A scholar is included among the top collaborators of Mark Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Lee. Mark Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 3 | |
| 4 | 25 | |
| 5 | 4 | |
| 6 | 10 | |
| 7 | 5 | |
| 8 | 75 | |
| 9 | 30 | |
| 10 | 2 | |
| 11 | 6 | |
| 12 | 24 | |
| 13 | 288 | |
| 14 | 20 | |
| 15 | 58 | |
| 16 | 38 | |
| 17 | 28 | |
| 18 | 57 | |
| 19 | 16 | |
| 20 | 24 |
About Mark Lee
Mark Lee is a scholar working on Otorhinolaryngology, Pathology and Forensic Medicine and Cancer Research, having authored 55 papers that have together received 1.7k indexed citations. Recurring topics across this work include Genetic factors in colorectal cancer (11 papers), Cancer Genomics and Diagnostics (8 papers) and Lung Cancer Treatments and Mutations (6 papers). The work is most often cited by research in Cancer Research (698 citations), Oncology (674 citations) and Pathology and Forensic Medicine (332 citations). Mark Lee has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Stefanie S. Jeffrey, Michail Ignatiadis, Alexander M. Aravanis, Richard D. Klausner, Kevin Struhl, Frederick L. Baehner, Drew Watson, David Kerr, Kim M. Clark-Langone and Claire Beaumont. Their work appears in journals such as Cell, Nature Medicine and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.